USDAnalytics, a leading market intelligence firm, has released its latest report, “Plant Genotyping Equipment Market Size, Trends, and Growth Opportunities 2026–2034.” The market, valued at $1,037.5 million in 2025, is projected to reach $2,348.1 million by 2034 at a CAGR of 9.5%. The report highlights the rapid transformation of plant breeding driven by next-generation sequencing, CRISPR-enabled crop development, and AI-powered genomic analytics. As global agriculture shifts toward climate-resilient and high-yield crops, investment in plant DNA sequencing systems, SNP genotyping platforms, and automated laboratory equipment is becoming a critical enabler of modern breeding programs.
Recent developments reflect strong consolidation and technological advancement. Solis Agrosciences integrated Ferris Genomics’ sequencing and bioinformatics platform to streamline breeding workflows, while Eurofins Genomics expanded NGS capacity through acquisition and centralized operations in Germany. MGI Tech introduced cost-efficient whole genome sequencing workflows, and Illumina launched 5-base DNA Prep kits enabling simultaneous variant and methylation detection. Qiagen advanced automation with QIAsymphony Connect, and LGC Biosearch introduced Amp-Seq One, simplifying genotyping workflows for high-volume breeding applications.
Key Market Dynamics
- PCR and qPCR systems accounted for 42.80% of the market by equipment type in 2025, driven by widespread use in molecular breeding workflows
- Genomic selection represented 34.80% of total demand in 2025, reflecting its role in accelerating crop improvement cycles
- Increasing adoption of next-generation sequencing platforms is reducing cost per sample and expanding large-scale genotyping
- Integration of AI and machine learning is improving genomic prediction accuracy and breeding efficiency
- Automation and high-throughput sample processing systems are reducing manual error and increasing laboratory productivity
- Rising demand for climate-resilient crops is driving investment in advanced genotyping and phenotyping technologies
Request a free sample of the report: 👉👉 Plant Genotyping Equipment Market
The plant genotyping equipment market is evolving toward integrated, high-throughput “lab-to-insight” platforms combining sequencing, sample preparation, and bioinformatics. Advances in next-generation sequencing, low-pass whole genome sequencing, and multi-omics technologies are enabling deeper genetic insights at lower costs. Simultaneously, portable sequencing systems and in-field diagnostics are decentralizing genotyping, allowing real-time crop analysis and faster breeding decisions in diverse agricultural environments.
Opportunities are expanding through genotype-to-phenotype integration and regulatory-driven adoption. AI-enabled phenotyping platforms are linking genetic data with agronomic performance, accelerating development of climate-resilient crops. Additionally, regulatory frameworks around seed traceability, genetic identity verification, and non-GMO certification are driving demand for rapid, high-accuracy genotyping systems. These trends position genotyping equipment as essential infrastructure across breeding, research, and agricultural quality assurance ecosystems.
The competitive landscape is defined by multi-omics integration, automation, and scalable sequencing technologies. Illumina leads with high-throughput sequencing platforms and AI-enabled genomic analytics, while Thermo Fisher Scientific expands accessible SNP genotyping solutions through global partnerships. QIAGEN is advancing automated sample-to-insight workflows, and LGC Biosearch delivers cost-efficient SNP genotyping with integrated robotics. Eurofins is scaling genotyping-as-a-service models with automated labs, while Agilent is integrating analytical instruments with digital lab ecosystems. Strategic focus across companies includes workflow integration, cloud-enabled analytics, and high-throughput genomic platforms supporting precision agriculture.
North America leads innovation and large-scale deployment, driven by federal genomics programs and advanced seed company infrastructure. The United States is integrating high-throughput sequencing, robotics, and AI-driven analytics into breeding pipelines, accelerating adoption of automated genotyping platforms.
Asia Pacific is emerging as a high-growth region, with China focusing on cost-efficient sequencing and regulatory incentives, while India is building coordinated genomics infrastructure through national biofoundry networks and precision breeding initiatives. Europe is advancing regulatory frameworks and phenomics integration, and Brazil is driving demand through climate-resilient crop programs and field-integrated genomic research. These regional dynamics are collectively shaping global adoption of advanced genotyping technologies.
Commenting on the findings, Mike, Senior Analyst, at USDAnalytics stated, “The Plant Genotyping Equipment Market is entering a high-growth phase where automation, AI-driven genomics, and multi-omics integration are redefining crop breeding efficiency. Our report provides a strategic roadmap for stakeholders to capitalize on the convergence of sequencing innovation, precision agriculture, and regulatory-driven demand shaping the future of global food systems.”
Plant Genotyping Equipment Market Report Scope
- Segmentation By Equipment Type (PCR & qPCR Systems, DNA Sequencing Systems, Microarray Equipment, Mass Spectrometry Systems, Capillary Electrophoresis Systems, Automated Liquid Handling Systems), By Genotyping Methodology (SNP Genotyping, Genotyping-by-Sequencing, SSR Genotyping, Whole Genome Sequencing), By Application (Marker-Assisted Selection, Marker-Assisted Backcrossing, Genomic Selection, Trait Mapping & Discovery, Seed Quality Control), By End-User (Agricultural Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations)
- Geographic Scope: Analysis spans 20+ countries across North America (US, Canada, Mexico), Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia), South America (Brazil, Argentina, Rest of South America), Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
- Analysis/ profiles of 10+ companies: Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., Danaher Corporation, PerkinElmer Inc., MGI Tech Co. Ltd., Pacific Biosciences of California Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Eurofins Scientific SE, BGI Genomics Co. Ltd., Oxford Nanopore Technologies plc, LGC Limited, LemnaTec GmbH, SGS SA, Others
- Timeframe: Historic data from 2021 to 2025 and forecast data from 2026 to 2034.
Media Contact:
Harry James
Sales Manager
USD Analytics
+1 213-510-3499
###